| Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients YH Cho, H Yazici, HC Wu, MB Terry, K Gonzalez, M Qu, N Dalay, ... Anticancer research 30 (7), 2489-2496, 2010 | 163 | 2010 |
| BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients H Yazici, O Bitisik, E Akisik, N Cabioglu, P Saip, M Muslumanoglu, ... British Journal of Cancer 83 (6), 737-742, 2000 | 79 | 2000 |
| P53 codon 72 genotypes in colon cancer. Association with human papillomavirus infection. N Sayhan, H Yazici, M Budak, O Bitisik, N Dalay Research communications in molecular pathology and pharmacology 109 (1-2), 25-34, 2001 | 73 | 2001 |
| Detection of human papillomavirus DNA by polymerase chain reaction and southern blot hybridization in colorectal cancer patients T Salepci, H Yazici, F Dane, E Topuz, N Dalay, H Onat, F Aykan, M Seker, ... J BUON 14 (3), 495-9, 2009 | 54 | 2009 |
| Global DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry L Delgado-Cruzata, HC Wu, M Perrin, Y Liao, MA Kappil, JS Ferris, ... Epigenetics 7 (8), 868-874, 2012 | 52 | 2012 |
| Aberrant Methylation of RASSF1A in Plasma DNA Before Breast Cancer Diagnosis in the Breast Cancer Family Registry H Yazici, MB Terry, YH Cho, RT Senie, Y Liao, I Andrulis, RM Santella Cancer epidemiology, biomarkers & prevention 18 (10), 2723-2725, 2009 | 52 | 2009 |
| Global hypomethylation in hepatocellular carcinoma and its relationship to aflatoxin B1 exposure YJ Zhang, HC Wu, H Yazici, MW Yu, PH Lee, RM Santella World Journal of Hepatology 4 (5), 169, 2012 | 51 | 2012 |
| BRCA1 and BRCA2 mutations in Turkish familial and non‐familial ovarian cancer patients: a high incidence of mutations in non‐familial cases H Yazici, G Glendon, H Yazici, SJ Burnie, P Saip, F Buyru, E Bengisu, ... Human mutation 20 (1), 28-34, 2002 | 41 | 2002 |
| c-erbB-2 gene amplification in nasopharyngeal carcinoma H Yazici, M Altun, C Alatli, O Dogan, N Dalay Cancer investigation 18 (1), 6-10, 2000 | 38 | 2000 |
| ARLTS1, MDM2 and RAD51 gene variations are associated with familial breast cancer E Akisik, H Yazici, N Dalay Molecular biology reports 38, 343-348, 2011 | 33 | 2011 |
| Investigation of the miR16-1 (C > T) + 7 Substitution in Seven Different Types of Cancer from Three Ethnic Groups H Yazici, J Zipprich, T Peng, EZ Akisik, H Tigli, M Isin, EE Akisik, MB Terry, ... Journal of Oncology 2009 (1), 827532, 2009 | 30 | 2009 |
| Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in … S Mirioglu, S Cinar, H Yazici, Y Ozluk, I Kilicaslan, A Gul, L Ocal, M Inanc, ... Lupus 29 (4), 379-388, 2020 | 26 | 2020 |
| p53 gene mutations are rare in human papillomavirus-associated colon cancer N Buyru, M Budak, H Yazici, N Dalay Oncology reports 10 (6), 2089-2092, 2003 | 26 | 2003 |
| New biomarkers in peripheral blood of patients with ovarian cancer: high expression levels of miR-16-5p, miR-17-5p, and miR-638 MA Saral, SB Tuncer, DA Odemis, OS Erdogan, SK Erciyas, P Saip, ... Archives of Gynecology and Obstetrics 305 (1), 193-201, 2022 | 25 | 2022 |
| miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and … SB Tuncer, OS Erdogan, SK Erciyas, MA Saral, B Celik, DA Odemis, ... Journal of ovarian research 13, 1-15, 2020 | 25 | 2020 |
| Cyp17 genetic polymorphism in prostate cancer and benign prostatic hyperplasia. H Tigli, H Yazici, N Dalay Research communications in molecular pathology and pharmacology 113, 307-314, 2003 | 23 | 2003 |
| Utility of c-crbB-2 Expression in Tissue and Sera of Ovarian Cancer Patients H Yazici, K Dolapcioglu, F Buyru, N Dalay Cancer investigation 18 (2), 110-114, 2000 | 22 | 2000 |
| Experiences of BRCA1/2 Gene Mutation–Positive Women with Cancer in Communicating Genetic Risk to Their Relatives M Seven, LL Shah, S Daack-Hirsch, H Yazici Cancer nursing 44 (3), E142-E150, 2021 | 20 | 2021 |
| A novel biomarker for post-transplant recurrent IgA nephropathy S Temurhan, SU Akgul, Y Caliskan, AS Artan, C Kekik, H Yazici, E Demir, ... Transplantation Proceedings 49 (3), 541-545, 2017 | 20 | 2017 |
| The expression levels of miRNA-15a and miRNA-16-1 in circulating tumor cells of patients with diffuse large B-cell lymphoma SB Tuncer, D Akdeniz, B Celik, S Kilic, O Sukruoglu, M Avsar, L Ozer, ... Molecular biology reports 46, 975-980, 2019 | 17 | 2019 |
